Background/Aim: To compare the quality of life (QOL) in patients undergoing transhiatal esophagectomy (THE) with or without chemotherapy, who were admitted to the Post Graduate Institute of Medical Education and Research, Chandigarh and enrolled in the study, from July 2004 to October 2005. Patients and Methods: Thirty patients of esophageal carcinoma by purposive sampling were randomized into two groups i.e., patients undergoing THE after chemotherapy and patients undergoing THE without chemotherapy. Two QOL questionnaires, one generic i.e., EORTC-QLQ C-30 (European Organization for Research and Treatment of Cancer) and other esophageal cancer-specific i.e., EORTC OES-18 were utilized to assess the QOL. Result: Physical functional scales w...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Esophageal cancer is currently the eighth most common cancer worldwide. Improvements in operative te...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
Contains fulltext : 57955.pdf (publisher's version ) (Closed access)PURPOSE: To as...
PurposeTo compare pre-agreed health-related quality of life (HRQOL) domains in patients with esophag...
ObjectiveWe sought to determine the effect of neoadjuvant chemoradiotherapy followed by surgical int...
Esophageal cancer is currently the eighth most common cancer worldwide. Improvements in operative te...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Esophageal cancer is currently the eighth most common cancer worldwide. Improvements in operative te...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
PURPOSE: To assess 3 years of quality of life in patients with esophageal cancer in a randomized tri...
Contains fulltext : 57955.pdf (publisher's version ) (Closed access)PURPOSE: To as...
PurposeTo compare pre-agreed health-related quality of life (HRQOL) domains in patients with esophag...
ObjectiveWe sought to determine the effect of neoadjuvant chemoradiotherapy followed by surgical int...
Esophageal cancer is currently the eighth most common cancer worldwide. Improvements in operative te...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esopha...
Esophageal cancer is currently the eighth most common cancer worldwide. Improvements in operative te...